Takeda—Upward revision to consolidated earnings forecast for the fiscal year ending March 2027 (IFRS basis) [DZH Individual Stock Information] (Jiji Press)

The story

Takeda Pharmaceutical Company Limited announced that consolidated operating profit for the fiscal year ending March 2027 is expected to be profitable. The expected profit was disclosed as ¥453 billion.

The announcement was reported as an upward revision calculated under IFRS, and attention is focused on the formal disclosure and updates to the earnings outlook.

At a glance

Fiscal periodOutlook for the fiscal year ending March 2027 announced

FigureConsolidated operating profit expected to be ¥453 billion

BasisUpward revision under IFRS

TimingAnnounced on the 29th

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

AgreesOpen

View the original filingThe timely-disclosure document itself

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.